HCN2

Chr 19AD

hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2

Also known as: BCNG-2, BCNG2, EIG17, FEB2, GEFSP11, HAC-1

The protein encoded by this gene is a hyperpolarization-activated cation channel involved in the generation of native pacemaker activity in the heart and in the brain. The encoded protein is activated by cAMP and can produce a fast, large current. Defects in this gene were noted as a possible cause of some forms of epilepsy. [provided by RefSeq, Jan 2017]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.453 OMIM phenotypes
Clinical SummaryHCN2
🧬
Gene-Disease Validity (ClinGen)
complex neurodevelopmental disorder · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

3 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.21) despite low pLI — interpret in context.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 258 VUS of 373 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint?
0.45LOEUF
pLI 0.489
Z-score 3.53
OE 0.21 (0.110.45)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
3.41Z-score
OE missense 0.53 (0.470.59)
222 obs / 418.4 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.21 (0.110.45)
00.351.4
Missense OE?0.53 (0.470.59)
00.61.4
Synonymous OE?1.55
01.21.6
LoF obs/exp: 5 / 23.5Missense obs/exp: 222 / 418.4Syn Z: -5.75

This gene — mechanism propensity

DN
0.6841th %ile
GOF
0.83top 10%
LOF
0.48top 25%

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation · 92% of P/LP are missense
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFGain-of-function HCN2 variants in genetic epilepsy1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 29064616

ClinVar Variant Classifications

373 submitted variants in ClinVar

Classification Summary

Pathogenic9
Likely Pathogenic3
VUS258
Likely Benign58
Benign24
Conflicting10
9
Pathogenic
3
Likely Pathogenic
258
VUS
58
Likely Benign
24
Benign
10
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
1
8
0
0
9
Likely Pathogenic
0
3
0
0
3
VUS
10
243
5
0
258
Likely Benign
1
26
4
27
58
Benign
0
1
9
14
24
Conflicting
10
Total122811841362

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

26 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap HCN2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

HCN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →